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1. Introduction 
The SeDeM expert system is a methodology which is applied in preformulation and 
formulation studies of medicines specifically in solid dosage forms. This system informs on 
the physical profile of powdered substances (APIs and excipients) used to formulate drugs 
(Suñé et al, 2005; García et al, 2010; Aguilar et al, 2009).  By determining whether powders 
(API or excipient) are suitable for direct compression, the SeDeM profile will inform about 
the advantages and gaps of those powdered substance to be used in direct compression, so 
the system informs on whether the direct compression method is appropriate (e.g.. wet 
granulation should be applied before compression). 
The characterization of powdered substances by SeDeM facilitates the identification of the 
characteristics that require amendment in order to obtain tablets by direct compression. This 
system thus provides information that will ensure the robust design of the formulation in 
the final product.  
This new method is based on the selection and application of several parameters that the 
formulation must fulfill to ensure a successful tablet elaborated by direct compression.  The 
following criteria are applied:  
a. The formulation must be representative and appropriate for the requirements of 
compression technology. 
b. The execution of the experimental methodology and calculus must be readily 
applicable.  
2. Parameters examined by the SeDeM method 
SeDeM uses 12 tests (Suñé et al, 2005; García et al, 2010; Aguilar et al, 2009) to examine 
whether a powder is suitable for direct compression.  
• Bulk density (Da) 
• Tapped density (Dc) 
• Inter-particle porosity (Ie) 
• Carr index (IC) 
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• Cohesion index (Icd) 
• Hausner ratio (IH) 
• Angle of repose (α) 
• Flowability (t″) 
• Loss on drying (%HR) 
• Hygroscopicity (%H) 
• Particle size (%Pf) 
• Homogeneity index (Iθ) 
These tests are grouped into five factors on the basis of the physical characteristics of the 
powder and the functionality of the drug: 
Dimensional Parameter. Bulk density (Da) and Tapped density (Dc). These affect the size of 
the tablet and its capacity to pile up. In addition, these tests are used in the calculus of other 
mathematical indexes for the determination of the compression parameter. 
Compressibility Parameter. Inter-particle porosity (Ie), Carr index (IC) and Cohesion index 
(Icd).   These affect the compressibility of the powder.  
Flowability/Powder Flow Parameter. Hausner ratio (IH), Angle of repose (α) and 
Flowability (t″). These influence the flowability of the powdered substance when 
compressed.  
Lubricity/Stability Parameter. Loss on drying (%HR) and Hygroscopicity (%H).  These 
affect the lubricity and future stability of the tablets. 
Lubricity/Dosage parameter. % Particles < 50 μm and Homogeneity Index. These influence 
the lubricity and dosage of the tablets. 
Table 1 shows the 5 parameters, with the abbreviations, units, formulas and incidence on 
compression. 
 
Incidence factor Parameter Symbol Unit Equation 
Bulk Density Da g/ml Da = P/Va Dimension 
Tapped Density Dc g/ml Dc = P/Vc 
Inter-particle 
Porosity 
Ie – Ie = Dc − Da/Dc × Da 
Carr Index IC % IC = (Dc − Da/Dc) 100 
Compressibility 
Cohesion Index Icd N Experimental 
Hausner Ratio IH – IH = Dc/Da 
Angle of Repose (α) ° tg α = h/r 
Flowability/Powder 
Flow 
Powder Flow t″ s Experimental 
Loss on Drying %HR % Experimental Lubricity/Stability 
Hygroscopicity %H % Experimental 
Particles < 50 μm %Pf % Experimental Lubricity/Dosage 
Homogeneity Index (Iθ) – * Iθ = Fm / 100 + Δ Fmn 
Table 1. Parameters and tests used by the SeDeM method.  
2.1 Experimental procedure used to study a powdered substance with parameters 
considered by the SeDeM method  
Pharmacopoeia methodologies are used to calculate these parameters. When this is 
impossible, a common strategy used in pharmaceutical technology development is applied. 
The methods used for each test are described below (Pérez et al, 2006): 
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• Bulk density (Da): The method is described in Section 2.9.34 of Eur. Ph. (Ph Eur, 2011) 
• Tapped density (Dc): The method is described in Section 2.9.34 of Eur. Ph. (Ph Eur, 2011) 
The volume taken is the value obtained after 2500 strokes using a settling apparatus 
with a graduated cylinder (voluminometer). 
• Inter-particle porosity (Ie) of the powder mixture (Font, 1962) is calculated from the 
following equation:  Ie=Dc-Da/Dc×Da 
• Carr index (IC%) (Córdoba et al, 1996; Rubinstein, 1993; Torres & Camacho, 1991; 
Wong, 1990). The method is described in Section 2.9.34 of Eur. Ph. (Ph Eur, 2011) This is 
calculated from Da and Dc as:  IC=(Dc-Da/Dc)100 
• Cohesion index (Icd): This index is determined by compressing the powder, preferably 
in an eccentric press. The mean hardness (N) of the tablets is calculated. First, the raw 
powder is tested, but if it cannot be compressed, 3.5% of the following mixture is added 
to the mix: talc 2.36%, Aerosil® 200 0.14% and magnesium stearate 1.00%.   
• Hausner ratio (IH) (Ph Eur, 2011; Rubinstein, 1993).  The method is described in Section 
2.9.34 of Eur Ph (Ph Eur, 2011). This is calculated from Da and Dc as:    IH=Dc/Da 
• Angle of repose (α) (Rubinstein, 1993, Muñoz, 1993). The method is described in Section 
2.9.36 of Eur Ph (Ph Eur, 2011). This is the angle of the cone formed when the product is 
passed through a funnel with the following dimensions: height 9.5 cm, upper diameter 
of spout 7.2 cm, internal diameter at the bottom, narrow end of spout 1.8 cm. The funnel 
is placed on a support 20 cm above the table surface, centred over a millimetre-grid 
sheet on which two intersecting lines are drawn, crossing at the centre. The spout is 
plugged and the funnel is filled with the product until it is flush with the top end of the 
spout when smoothed with a spatula. Remove the plug and allow the powder to fall 
onto the millimetre sheet. Measure the four radii of the cone base with a slide calliper 
and calculate the mean value (r). Measure the cone height (h). Deduce α from 
tan(α)=h/r. 
• Flowability (t″):  The method is described in Section 2.9.16 of Eur. Ph (Ph Eur, 2011). It is 
expressed in seconds and tenths of a second per 100 grams of sample, with a mean 
value of three measurements. 
• Loss on drying (%HR): This is measured by the method described in 2.2.32 in Eur. Ph 
(Ph Eur, 2011). The sample is dried in an oven at 105 °C ± 2 °C, until a constant weight 
is obtained. 
• Hygroscopicity (%H): Determination of the percentage increase in sample weight after 
being kept in a humidifier at a relative humidity of 76% (±2%) and a temperature of 
22°C± 2°C for 24 h. 
• Percentage of particles measuring <50 μm (%Pf): Particle size is determined by means of 
the sieve test following the General method 2.9.12 of Eur. Ph. (Ph Eur, 2011). The value 
returned is the % of particles that pass through a 0.05-mm sieve when vibrated for 
10 min at speed 10 (CISA vibrator). 
• Homogeneity index (Iθ):  This is calculated according to the General method 2.9.12 of 
Eur. Ph (Ph Eur, 2011).To determine particle size by means of the sieve test, the grain 
size of a 100g sample is measured by subjecting a sieve stack to vibration for 10 min at 
speed 10 (CISA vibrator). The sieve sizes used are 0.355 mm, 0.212 mm, 0.100 mm and 
0.05 mm. The percentage of product retained in each sieve is calculated and the amount 
that passes through the 0.05mm sieve is measured. The percentage of fine particles 
(<50 μm) (%Pf) was calculated as described above. Note that if this percentage is higher 
than that calculated in the complete sieve test, it is because some of the particles become 
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adhered to the product retained in the sieves during the grain-size test, and the 
percentage of <50 μm particles found may be lower than the true figure. The following 
equation is then applied to the data obtained.  
( ) ( ) ( ) ( )
( ) ( )
Fm
*I
100 dm dm-1 Fm-1 dm+1 dm Fm+1 dm dm-2 Fm-2 dm+2 dm Fm+2 ....
dm dm-n Fm-n dm+n dm Fm+n
θ =
+ − + − + − + − +
+ − + −
(1)
 
Where: 
• Iθ, Relative homogeneity index. Particle-size homogeneity in the range of the fractions 
studied;  
• Fm, percentage of particles in the majority range;  
• Fm−1, percentage of particles in the range immediately below the majority range;  
• Fm+1, percentage of particles in the range immediately above the majority range;  
• n, order number of the fraction studied under a series, with respect to the major fraction;  
• dm, mean diameter of the particles in the major fraction;  
• dm−1, mean diameter of the particles in the fraction of the range immediately below the 
majority range;  
• dm+1, mean diameter of the particles in the fraction of the range immediately above the 
majority range. 
2.2 Determination of acceptable limit values for each parameter included by the 
SeDeM method 
Having obtained the values as described above, certain limits are set (Table 2) on the basis of 
the parameters chosen and the values described in the Handbook of Pharmaceutical 
Excipients (Kibbe, 2006), or alternatively on the basis of experimental tests. 
 
Incidence Parameter Acceptable range 
Bulk density 0–1 g/ml Dimension 
Tapped density 0-1 g/ml 
Inter-particle porosity 0–1.2 
Carr index 0–50 (%) 
Compressibility 
Cohesion index 0–200 (N) 
Hausner ratio 3–1 
Angle of repose 50–0 (°) 
Flowability/powder flow 
Powder flow 20–0 (s) 
Loss on drying 0-10 (%) Lubricity/stability 
Higroscopicity 20–0 (%) 
Particles < 50 μ 50–0 (%) Lubricity/dosage 
Homogeneity index 0–2 × 10−2 
 
Table 2. Limit values accepted for the SeDeM Diagram  parameters. 
The rationale to establish the limits for each parameter is: 
• Da, Dc, Ie e IC are calculated from the extreme values (excluding the most extreme 
values) described in “Handbook of Pharmaceutical Excipients” (Kibbe, 2006). For the 
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Carr Index, limits are based on references in “Tecnologia Farmaceutica” by S. Casadio 
(Casadio, 1972) and on monograph 2.9.36 of Ph Eur (Ph Eur, 2011). 
• Icd. The limit is determined empirically from compression tests on many powdered 
substances, based on the maximum hardness obtained without producing capped or 
broken tablets. This hardness is then established as the maximum limit. The minimum 
value is “0”. This value implies that no tablets are obtained when the powders are 
compressed. 
• IH, Powder flow, repose angle. The limits are set on the basis of the monographs 
described in “Handbook of Pharmaceutical Excipients” (Kibbe, 2006), and  monograph 
2.9.36 of Ph Eur (Ph Eur, 2011) or other references in  “Tecnologia Farmaceutica” by S. 
Casadio (Casadio, 1972).  
• %HR. The limits are established on the basis of the references cited elsewhere, such as 
“Farmacotecnia teórica y práctica” by José Helman (Helman, 1981). The optimum 
humidity is between 1% to 3%.  
• Hygroscopicity is based on the “Handbook of Pharmaceutical Excipients” (Kibbe, 2006): 
based on manitol (not hygroscopic) and sorbitol (highly hygroscopic). 
• Particle size. The limits are based on the literature. These sources (Kibbe, 2006) report 
that rheological and compression problems occur when the percentage of fine particles 
in the formulation exceeds 25%. 
The limits for the Homogeneity Index (Iθ) are based on the distribution of the particles of the 
powder (see Table 3, indicating the size of the sieve (in mm), average particle size in each 
fraction and the difference in average particle size in the fraction between 0.100 and 0.212 
and the others). A value of 5 on a scale from 0 to 10 was defined as the minimum acceptable 
value (MAV), as follows: 
 
Sieve 
(mm) 
Corresponding 
fraction 
Average of the 
diameter of the 
fraction 
Corresponding 
diameter 
(dm ... dm ± n) 
Dif dm with 
the  mayor 
component 
0,355 – 0,500 Fm+2 427 dm+2 271 
0,212 – 0,355 Fm+1 283 dm+1 127 
0,100 – 0,212 Fm 156 dm 0 
0,050 –0,100 Fm-1 75 dm-1 81 
< 0,050 Fm-2 25 dm-2 131 
Table 3. Distribution of particles in the determination of Iθ.   
The major fraction (Fm) corresponds to the interval from 0.100 to 0.212 mm, because it falls 
in the middle of the other fractions of the table. This interval is calculated as the proportion 
in which the powder particles are found in each fraction considered in the table (as 
described above). Those particles located in the major fraction (Fm) in a proportion of 60% 
are considered to represent the MAV of 5. The distributions of the other particles are 
considered to be Gaussian. The limits for the Homogeneity Index are set between 0 and 0.02. 
2.3 Conversion of the limits considered in each parameter of the SeDeM method into 
the radius (r) of the SeDeM Diagram 
The numerical values of the parameters of the powder, which are obtained experimentally 
(v) as described above, are placed on a scale from 0 to 10, considering 5 as the MAV. 
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Incidence Parameter 
Limit value 
(v) 
Radius 
(r) 
Factor 
applied to v 
Bulk density 0–1 0–10 10v Dimensions 
Tapped density 0–1 0–10 10v 
Inter-particle porosity 0–1.2 0–10 10v/1.2 
Carr index 0–50 0–10 v/5 
Compressibility 
Cohesion index 0–200 0–10 v/20 
Hausner ratio (a)  3–1 0–10 (30-10v)/2 
Angle of repose 50–0 0–10 10 − (v/5) 
Flowability/powder 
flow 
Powder flow 20–0 0–10 10 − (v/2) 
Loss on drying (b)  10-0 0-10 10-v Lubricity/estability 
Higroscopicity 20–0 0–10 10 − (v/2) 
Particles < 50 μ 50–0 0–10 10 − (v/5) Lubricity/dosage 
Homogeneity index 0–2 × 10−2 0–10 500v 
Table 4. Conversion of limits for each parameter into radius values (r). 
(a)   The values that exceptionally appear below 1 are considered values corresponding to 
non-sliding products.  
(b)   Initially, relative humidity was calculated based on the establishment of three intervals 
because the percentage relation obtained from the measurement of the humidity of the 
substance does not follow a linear relation with respect to the correct behaviour of the dust. 
Humidity below 1% makes the powder too dry, and electrostatic charge is induced, which 
affects the rheology. Furthermore, low humidity percentages do not allow compression of the 
substance (moisture is necessary for compacting powders). Moreover, more than 3% moisture 
causes caking, in addition to favouring the adhesion to punches and dyes. Consequently, it 
was considered that this parameter should present optimal experimental values from 1% to 3% 
(Braidotti, 1974). Nevertheless,  experience using  the SeDeM Diagram has demonstrated no 
significant variations in the results, so the previous three intervals of relative humidity can be 
simplified to the calculation of the parameter, thus finally the linear criterion of treatment of 
results is adopted (Suñé et al, 2011).  
The correspondence of the value of the parameters with this scale takes into account the limit 
values (see 2.2), using the factors indicated in Table 4. When all radius values are 10, the 
SeDeM Diagram takes the form of a circumscribed regular polygon, drawn by connecting all 
the radius values of the parameters with linear segments. Table 4 shows the factors used for 
calculating the numerical value of each parameter required for the SeDeM method.  
2.4 Graphical representation of the SeDeM Diagram 
When all radius values are 10, the SeDeM Diagram takes the form of a circumscribed regular 
polygon, drawn by connecting the radius values with linear segments. The results obtained 
from the earlier parameter calculations and conversions are represented by the radius. The 
figure formed indicates the characteristics of the product and of each parameter that 
determines whether the product is suitable for direct compression. In this case, the SeDeM 
Diagram is made up of 12 parameters, thus forming an irregular 12-sided polygon (Figure 1). 
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Fig. 1. The SeDeM Diagram with 12 parameters. 
2.5 Acceptable limits for Indexes 
To determine whether the product is suitable for direct compression using a numerical 
method, the following indexes are calculated based on the SeDeM Diagram as follows: 
  
n P 5
 Parameter index     IP=
n Pt
≥
−
c
c  (2) 
Where: 
No. p ≥ 5: Indicates the number of parameters whose value is equal to or higher than 5 
No. Pt: Indicates the total number of parameters studied 
The acceptability limit would correspond to: 
 
º 5
0,5
º
n P
IP
n Pt
≥
= =  (3) 
 
( ) Parameter profile Index     IPP Average of   r  all parameters− =
 (4) 
Average (r) = mean value of the parameters calculated. 
The acceptability limit would correspond to:   IPP = media (r) = 5 
 
Good Compressibility Index     IGC=IPP x f−
 (5) 
 
Polygon area
f      Reliability factor
Circle area
= =
 (6) 
The acceptability limit would correspond to: ICG = IPP x f = 5.  
The reliability factor indicates that the inclusion of more parameters increases the reliability 
of the method (Figure 2). 
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Fig. 2. On the left graph with ∞ parameters (maximum reliability), f = 1. In the center, graph 
with 12 parameters (nº of parameters in this study), f = 0.952. On the right, graph with 8 
parameters (minimum reliability), f = 0.900. 
3. Practical applications of SeDeM 
3.1 Determination of the suitability of an API to be subjected to direct compression 
technology 
Here we used the SeDeM method to characterize an active product ingredient in powder 
form (API SX-325) and to determine whether it is suitable for direct compression, applying 
the profile to the SeDeM Diagram. 
We measured the 12 parameters proposed in the SeDeM method following the procedures 
indicated. Thus we obtained the values on which the factors set out in Table 5 are applied to 
obtain the numerical values corresponding to the radius of the diagram and the values of 
the mean incidence. All the values in Table 5 correspond to the average of two 
determinations. The radius values are represented in the diagram shown in Figure 3. 
 
0
5
10
Da
Dc
Ie
IC
Icd
IH
(α )
t
%HR
%H
% Pf
(Iθ )
 
Fig. 3. SeDeM Diagram for API SX-325. 
To obtain the indices of acceptance or qualification for formulation by direct compression, 
the formulas corresponding to the parametric index were applied from the numerical results 
of the radius shown in Table 5. The results of the acceptance indices are shown in Table 6. 
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Incidence factor Parameter Symbol Unit Value 
(v) 
(r) Mean 
incidence 
Bulk Density Da g/ml 0.448 4.48 Dimension 
Tapped Density Dc g/ml 0.583 5.83 
5.16 
Inter-particle Porosity Ie – 0.517 4.31 
Carr Index IC % 23.156 4.63 
Compressibility 
Cohesion Index Icd N 118.00 5.90 
4.95 
Hausner Ratio IH – 1.868 5.66 
Angle of Repose (α) ° 25.770 4.85 
Flowability/Powder 
Flow 
Powder Flow t s 1.500 9.25 
6.59 
Loss on Drying %HR % 5.650 4.35 Lubricity/Stability 
Hygroscopicity %H % 15.210 2.40 
3.37 
Particles < 50 μm %Pf % 0.000 10.0 Lubricity/Dosage 
Homogeneity Index (Iθ) – 0.0058 2.90 
6.45 
Table 5. Application of the SeDeM method to API in powder form (API SX-325), and 
calculation of radii. 
  
Parameter index  0.42  
Parametric profile index (mean r of all parameters)  5.38  
Good compression index (IGC)  5.12  
Table 6. SeDeM acceptance index for API SX-325 
On the basis of the results of the radius corresponding to the SeDeM Diagram, the 
parametric profile was > 5. This value implies that API SX-325 is suitable for direct 
compression. However, in order to discern the appropriateness of this substance for this 
formulation technology, we analyzed the 5 groups of individual factors classified by the 
type of incidence in this compression.  
In the case study above, only the parameters involved in the general factor of denominated 
incidence lubrication/stability presented values below 5 (median = 3.37). This finding 
implies deficient rheological qualities and poor stability, expressed by a high intrinsic 
humidity of balance and high hygroscopicity. The product tended to capture humidity, thus 
worsening the rheological profile (compression, lack of flow) and consequently impairing its 
stability. These deficiencies are reflected graphically in the SeDeM Diagram, which shows 
that a large shaded area (activity area) (the greater the shaded area, the more suitable the 
characteristics for direct compression) is present for most of the parameters. However, some 
parameters show a small shaded area, thus indicating that the powder is not suitable for 
direct compression. 
In this regard, the SeDeM method informed (table 5) on the following for API SX-325: it is a 
dusty substance with correct dimensional characteristics (Da and Dc); it shows moderately 
acceptable compressibility (IE, IC, Icd), which can be improved with the addition of 
excipients of direct compression (DC); it shows very good fluidity/flowability (IH, α, t”) 
and correct lubrication/dosage (%Pf, Iθ). Given these characteristics API SX-325 is suitable 
for compression with the addition of standardized formula of lubricant. The group of factors 
with deficient incidence corresponds to lubricity/stability and, considering the parameters 
HR and H, corrective measures can be taken to prevent its negative influence on direct 
compression. These measures include drying the material and preparing the tablet in rooms 
with controlled relative humidity below 25%. 
www.intechopen.com
 
Expert Systems for Human, Materials and Automation 
 
26 
The results given by the SeDeM method in this example demonstrate that it is reliable in 
establishing whether powdered substances have suitable profiles to be subjected to direct 
compression. Consequently, SeDeM is a tool that will contribute to preformulation studies 
of medicines and help to define the manufacturing technology required. Indeed, the 
application of the SeDeM Diagram allows the determination of the direct compression 
behaviour of a powdered substance from the index of parametric profile (IPP) and the index 
of good compression (IGC), in such a way that an IPP and an IGC equal or over 5 indicates 
that the powder displays characteristics that make it suitable for direct compression, adding 
only a small amount of lubricant (3.5% of the magnesium stearate, talc and Aerosil® 200). 
Also, with IPP and IGC values between 3 and 5, the substance will require a DC diluent 
excipient suitable for direct compression.  In addition, it is deduced that techniques other 
than direct compression (wet granulation or dry granulation) will be required for APIs with 
IPP and IGC values below 3. 
The SeDeM Diagram is not restricted to active products since it can also be used with new or 
known excipients to assess their suitability for application as adjuvants in direct 
compression. Thus, knowledge of excipient profiles, with their corresponding parameters, 
will allow identification of the most suitable excipient to correct the characteristics of APIs 
registering values under 5. 
Of note, the greater the number of parameters selected, the greater the reliability of the 
method, in such a way that to obtain a reliability of the 100%, the number of parameters 
applied would have to be infinite (reliability factor = 1). The number of parameters could be 
extended using additional complementary ones, such as the true density, the index of 
porosity, the electrostatic charge, the specific surface, the adsorption power, % of 
lubrication, % friability, and the index of elasticity. However, while improving the reliability 
of the method, the inclusion of further parameters would be to the detriment of its 
simplicity and rapidity, since complementary parameters are difficult to apply. 
3.2 Application of the SeDeM method to determine the amount of excipient required 
for the compression of an API that is not apt for direct compression 
Experimental determination of the parameters of the SeDeM method for a range of APIs and 
excipients allows definition of their corresponding compressibility profiles and their 
subsequent mathematical treatment and graphical expression (SeDeM Diagram). Various 
excipient diluents can be analyzed to determine whether a substance is appropriate for 
direct compression and the optimal proportion of excipient required to design a suitable 
formulation for direct compression based on the SeDeM characteristics of the API (Suñé et 
al, 2008a). In this regard, the SeDeM method is a valid tool with which to design the 
formulation of tablets by direct compression. 
The mathematical equation can be applied to the 5 parameters (dimension, compressibility, 
flowability/powder flow, lubricity/stability lubricity/dosage) considered deficient by the 
SeDeM system.  The mathematical equation is applied to correct a deficient parameter of the 
API. The equation proposed (Equation 7) allows calculation of the amount of excipient 
required to compress the API on the basis of the SeDeM radius considered minimum (5) for 
each parameter of incidence that allows correct compression. 
 
RE R
CP 100 100
RE RP
−⎛ ⎞
= − ×⎜ ⎟
−⎝ ⎠   (7) 
Where: 
CP = % of corrective excipient 
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RE = mean-incidence radius value (compressibility) of the corrective excipient 
R = mean-incidence radius value to be obtained in the blend 
RP = mean-incidence radius value (compressibility) of the API to be corrected 
The unknown values are replaced by the calculated ones required for each substance in 
order to obtain R = 5 (5 is the minimum value considered necessary to achieve satisfactory 
compression). For example, if a deficient compressibility parameter for an API requires 
correction, Equation 7 is applied by replacing the terms RE and RP with the values 
calculated for each substance with the purpose to obtain a R=5, thus obtaining the optimal 
excipient to design a first drug formulation and the maximum amount required for a 
comprehensive understanding of the proposed formula. From this first formulation, 
research can get underway for the final optimization of the formulation, taking into 
consideration the biopharmaceutical characteristics required in the final tablet 
(disintegration, dissolution, etc). We thus present a method to establish the details of the 
formulation of a given drug by direct compression.  
3.2.1 Practical application of the mathematical equation to calculate the amount of 
excipient required for a deficient API to be subjected to direct compression 
technology 
When an API requires an appropriate formula for the direct compression, it must be 
characterized following the SeDeM Diagram. Furthermore, a series of excipients used for 
DC are also characterized using the diagram. If the API has deficient compressibility 
parameters (<5), it is mixed with an excipient with a satisfactory compressibility parameter 
(>5), thereby correcting the deficiency. The excipient that shows the smallest amount to 
correct this parameter should be used. The amount of excipient is determined by the 
mathematical equation of the SeDeM system (Equation 7). 
Here we describe an example using an API 842SD and 6 diluents used for DC. The 
corresponding parameters and the radius mean values obtained with samples of this 
substance are shown in Table 7 and the parameters and the radius mean values of six 
excipient diluents used in DC are shown in Table 8 (Suñé et al, 2008a). 
 
Incidence factor Parameter Symbol Unit Value (v) (r) Mean 
incidence 
Bulk Density Da g/ml 0.775 7.75 Dimension 
Tapped Density Dc g/ml 1.140 10.00 
8.88 
Inter-particle Porosity Ie – 0.413 3.44 
Carr Index IC % 32.018 6.40 
Compressibility 
Cohesion Index Icd N 7.330 0.37 
3.40 
Hausner Ratio IH – 1.98 5.10 
Angle of Repose (α) ° 37.450 2.51 
Flowability/Powder 
Flow 
Powder Flow t s 10.330 4.84 
4.15 
Loss on Drying %HR % 9.865 0.68 Lubricity/Stability 
Hygroscopicity %H % 0.007 10.0 
5.34 
Particles < 50 μm %Pf % 12.000 7.60 Lubricity/Dosage 
Homogeneity Index (Iθ)  0.0024 1.20 
4.40 
Parameter index 0.50 
Parametric profile index (mean r of all parameters) 4.99 
Good compression index (IGC) 4.75 
Table 7. Parameters, mean incidence and parametric index for API 842SD 
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Avicel  
PH 101 
Batch 6410C 
3.47 4.63 6.02 5.01 10.00 5.55 3.46 0.00 3.84 8.17 3.38 10.00 4.05 7.01 3.01 
Isomalt® 
Batch LRE 539 
4.40 5.60 4.06 4.29 10.00 5.76 6.24 6.85 4.01 9.89 9.00 2.00 5.00 6.11 6.28 
Kleptose® 
Batch 774639 
5.58 8.46 5.08 6.81 10.00 4.95 3.51 6.50 0.00 8.12 3.60 1.90 7.02 7.30 4.98 
Kollindon® 
VA64 
Batch 28-2921 
2.53 3.43 8.64 5.25 6.91 5.48 6.04 5.25 3.19 2.85 8.40 5.50 2.98 6.93 5.59 
Plasdone 
®S630 
Batch 6272473 
2.48 3.73 10.00 6.70 10.00 4.99 4.13 0.00 3.46 3.17 3.60 5.70 3.11 8.90 3.04 
Prosolv® 
HD90 
Batch K950044 
4.86 5.96 3.17 3.69 10.00 5.91 5.99 6.75 3.44 8.86 6.24 10.00 5.41 5.62 6.22 
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Fig. 4. SeDeM Diagram for API 842SD 
The SeDeM Diagram for API 842SD (Figure 4, Table 7) indicates that this substance has 
deficient compressibility (r=3.40), limited rheological characteristics (r=4.15) and low 
lubricity/dosage (r=4.40). Consequently, to apply direct compression to API 842SD, it 
requires formulation with an excipient that enhances the compressibility factor. This 
excipient is identified by the SeDeM system. 
In order to select the excipient and the concentration used to correct the deficiencies and, in 
particular, the compressibility, we applied the mathematical equation of the SeDeM Expert 
system (Equation 7): replacing the unknowns (RE and RP) with the values calculated for 
each substance (RE for excipients and RP for API) with aim to obtain R=5. The results 
obtained are shown in Table 9. 
 
EXCIPIENT Avicel® 
PH101 
Kleptose® Koll 
VA® 
Plasdone® 
S630 
Prosolv® 
HD90 
Isolmalt® 
721 
      
7.01 7.30 6.93 8.90 5.62 6.11 
3.40 3.40 3.40 3.40 3.40 3.40 
5.00 5.00 5.00 5.00 5.00 5.00 
 
RE 
RP (API) 
R 
      
% excipient 44.32 41.03 45.33 29.09 72.07 59.04 
Table 9. Amount of excipient required to be mixed with the API to obtain a compressibility 
factor equal to 5. 
Plasdone S630 was the most suitable excipient to correct the deficit (compressibility) of API 
842SD with the lowest concentration (29.09 %). (Table 9) 
To better understand the SeDeM system, the graphical representations of the profiles of the 
API and the excipient can be superposed. Figure 5 shows how the deficiencies of an API 
would be compensated when formulated. The green line corresponds to the excipient that 
theoretically provides the final mixture the characteristics to be compressed.  In this way, 
the information provided by the SeDeM system allows the formulator to start working with 
excipients that have a high probability to provide suitable formulations, thus reducing the 
lead time of formulation.  
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Fig. 5. Green indicates the part that corresponds to the excipient that provides suitable 
compressibility to the final mixture with the API (in yellow). Three excipients are shown, all 
of them covering the deficiencies of the API. 
3.3 Application of the SeDeM system to the quality control of batches of a single API 
or excipient used for direct compression 
The SeDeM system is also apt for verification of the reproducibility of manufacturing 
standards between batches of the same powdered raw material (API or excipient). Indeed, 
superposing the SeDeM Diagrams of each batch, the degree of similarity or difference 
between the same API on the basis of the established parameters can determine its 
appropriateness for compression.  
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Fig. 6. SeDeM Diagram of 3 batches of API FO130. 
The SeDeM method is also a useful tool for the study of the reproducibility of a 
manufacturing method used for a powdered substance and, thus of the validation of 
systematic variation during elaboration. A manufacturing process gives rise to variations 
in the final product and these variations must fall within limits or established 
specifications. By applying the SeDeM method to study reproducibility between batches 
of the same API or excipient, specifications in the different parameters can be established 
to ensure the same quality of the product regardless of the batch analyzed. In addition, 
these specifications must be used for the establishment of particular limits for quality 
control applications. To achieve this goal it is necessary to study the parameters of the 
SeDeM Diagram, applying the same statistic analyses required to establish the 
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pharmacotechnical equivalence between batches. Correct reproducibility between batches 
will ensure the reproducibility and the quality of the tablets formulated with this API or 
excipient, regardless of the batch used. 
Figure 6 shows the SeDeM Diagrams of three batches from the same API (Perez et al, 2006). 
In this case the mark and the indices were very similar.  This control has the advantage that 
the method has the capacity to detect variations in particle size between batches of the 
product. This capacity thus contributes to the formulation of the pharmaceutical forms and 
their correct dissolution. 
3.4 Application of the SeDeM method to differentiate the excipient in the same 
chemical family  
The SeDeM system also allows differentiation between excipients of the same chemical 
family but that differ in physical characteristics. These characteristics will determine their 
use in a formulation for direct compression of a given API. In a previous study (Suñé et al, 
2008b) several lactoses were characterized, and in figure 7 can be observed the clear 
differentiation that makes the SeDeM methodology between the same chemical substances 
(but different functionally). 
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Fig. 7. SeDeM Diagram for three kinds of lactose. On the left: Lactose anhydre IGC: 5.39. In 
the center: Lactose monohydrate IGC: 4.83. On the right: Lactose fast-flow IGC: 6.30.  
3.5 Application of the SeDeM Diagram to differentiate excipients of the same 
functional type 
Also, the SeDeM Expert system allows differentiation between excipients from the same 
functional type, for example disintegrants or diluents. In the former, the SeDeM 
characterization provides the information required to predict the difficulties encountered for 
compression.  
By quantifying the 12 tests provided by the system, the deficient values for their 
compression can be defined; on the basis of these values, an adequate (applying the same 
SeDeM Diagram) substance can be selected to improve the compressibility in the final 
mixture of the disintegrants and the API. Figure 8 shows the characterization of several 
disintegrants using the SeDeM technique, where the differences between each one in 
relation to their major or minor compression capacity are shown, although all are used 
because of their disintegrant function (Aguilar et al, 2009).  
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Fig. 8. SeDeM diagram for several disintegrant excipients. 
3.6 The new model SeDeM-ODT to develop orally disintegrating tablets by direct 
compression 
This innovative tool is the new SeDeM-ODT model which provides the Index of Good 
Compressibility & Bucodispersibility (IGCB index) obtained from the previous SeDeM method 
(Aguilar et al, 2011).  The IGCB index is composed by 6 factors that indicate whether a mixture 
of powder lends itself to be subjected to direct compression. Moreover, the index 
simultaneously indicates whether these tablets are suitable as bucodispersible tablet 
(disintegration in less than 3 minutes). The new factor, disgregability (Table 10), has three 
parameters that influence this parameter. The graph now comprises 15 parameters (Figure 9). 
  
Factor Parameter Limit value (v) Radius 
Effervescence 0-5 (minutes) 10-0 
Disintegration Time with disc (DCD) 0-3(minutes) 10-0 
Disgregability 
Disintegration Time without disc (DSD) 0-3 (minutes) 10-0 
Table 10. The new factor disgregability is added to the SeDeM expert system to achieve the 
SeDeM-ODT expert system. 
 
 
Fig. 9. SeDeM-ODT Diagram 
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4. Conclusions 
Here we developed an original methodology for the preformulation and powder substance 
characterization. This method facilitates studies on the design and development of 
formulations for the production of tablets by direct compression. The SeDeM expert system 
is a useful tool because, in addition to considering the type of components, it also provides 
recommendations on intrinsic properties, such as the characteristics and morphology of the 
particles. We propose that given the accuracy of the information provided by this system, 
formulations will have a higher probability of being successfully compressed.  
This method characterizes the individual components of a formulation and applies a 
mathematical analysis to determine the exact amount of each in the final formulation. 
The formulation provided will be valid for direct compression. This manufacturing 
procedure offers many advantages from a production perspective. In addition to being 
faster than other techniques, it is straightforward as it reduces the number of steps during 
the manufacturing process. 
In addition SeDeM has the advantage of providing formulation with the lowest amount of 
excipients as it combines the API with only one excipient and the standard formula of 
lubricants, thus avoiding the used of unnecessary excipients, such as diluents, binders and 
agglutinants.  
The information given by the SeDeM system contributes to a Quality by Design 
Development. Consequently, this innovative tool is consistent with the current requirements 
of regulatory health authorities such as the FDA and ICH.  
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